The Lam Foundation

Non Profit Organization Management, 4520 Cooper Rd, Cincinnati, Ohio, 45242, United States, 1-10 Employees

Phone Number: +15*********

Who is THE LAM FOUNDATION

The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) through advocacy and the funding of promising research. We are d...

Get Full Access

Headquarters: 4520 Cooper Rd, Cincinnati, Ohio, 45242, United States
Date Founded: 1995
Employees: 1-10
Revenue: $10 Million to $25 Million
Active Tech Stack: See technologies
CEO: Susan Mha
- Email
- Phone

Industry: Non Profit Organization Management

SIC Code: 7389 | NAICS Code: 624190 | Show More

Does something look wrong? Fix it. | View contact records from THE LAM FOUNDATION

The LAM Foundation Org Chart and Mapping

Susan Mha

Chief Executive Officer & Executive Director

Email
Phone

Employees

Julie Wogenstahl

Administrative and Data Coordinator

Email
Phone

See Full Org Chart

View Email Formats for The LAM Foundation

You are signed out

Join Now

Free credits every month

Frequently Asked Questions Regarding The LAM Foundation

Answer: The LAM Foundation's headquarters are located at 4520 Cooper Rd, Cincinnati, Ohio, 45242, United States

Answer: The LAM Foundation urgently seeks safe and effective treatments, and ultimately a cure, for lymphangioleiomyomatosis (LAM) through advocacy and the funding of promising research. We are dedicated to serving the scientific, medical and patient communities by offering information, resources, and a worldwide network of hope and support. The LAM Foundation is the global leader in the fight against lymphangioleiomyomatosis (LAM). Founded in 1995 as a grass roots effort, The LAM Foundation has evolved into an organization that is described by the National Heart, Lung and Blood Institute (NHLBI) as "a model for voluntary health agencies." LAM is a rare and progressive lung disease that primarily affects women and has no known cure. Headquartered in Cincinnati, Ohio, The LAM Foundation provides support and education for women with LAM and their families, engages doctors and scientists to continue to learn more about the disease and raises funds for continued research. In May 2015, the FDA approved Rapamune as the first effective treatment for LAM, based on research and patient engagement supported by The LAM Foundation. Through the efforts of a committed Board of Directors and staff, the Foundation has raised more than $26 million in 24 years. Over 60% of this has been committed to research which further seeded an estimated $40 million in subsequent funding from federal sources to advance the field of LAM research. This research effort has produced more than 125 grant-related publications, a diagnostic biomarker that can obviate the need for lung biopsy, and a pivotal clinical trial that has identified the first treatment. In addition to its world-renowned Scientific Board, 60+ LAM Clinics have been established across the globe which focus referrals to expert regional centers and facilitate clinical trials. This distributed expertise model fosters scientific interest in LAM at academic medical centers around the country and provides care close to home.